Centre for the AIDS Programme of Research in South Africa
Quick facts
Marketed products
- Tenofovir, lamivudine and efavirenz · Infectious Disease / Virology
This fixed-dose combination of three antiretroviral drugs inhibits HIV reverse transcriptase and integrase to suppress viral replication.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Centre for the AIDS Programme of Research in South Africa portfolio CI brief
- Centre for the AIDS Programme of Research in South Africa pipeline updates RSS
Frequently asked questions about Centre for the AIDS Programme of Research in South Africa
What are Centre for the AIDS Programme of Research in South Africa's marketed drugs?
Top marketed products include Tenofovir, lamivudine and efavirenz.
Related
- Tenofovir, lamivudine and efavirenz · Infectious Disease / Virology
- Sector hub: All tracked pharma companies